This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 18Jan 2018

    Chance of survival from ovarian cancer greater with chemo lavage of the abdominal cavity (1)

    In women with metastases of ovarian cancer restricted to the abdominal cavity (stage III), it appears that hyperthermic intraperitoneal chemotherapy, HIPEC, improves the survival rate by 10%.

    Read More
  • 16Jan 2018

    DNA researcher Judith Haarhuis wins Antoni van Leeuwenhoek Award 2017

    Judith Haarhuis, postdoc in the research group headed by Benjamin Rowland, has won the Antoni van Leeuwenhoek Award 2017, thanks to her fundamental discoveries in chromosome biology.

    Read More
  • 16Jan 2018

    Personalized cancer treatment 2.0: new combination strategy developed

    A new anti-cancer combination strategy targets different cell groups within single tumors based on their respective drug sensitivities. This is a new way to tackle drug resistance in tumors. Publication Julia Boshuizen e.a. in Nature Medicine 2018-01-15

    Read More
  • 20Dec 2017

    Predicting treatment outcome by DNA and organoids

    Tailoring treatment to the unique cancer of each individual patient is important to improve patient outcomes, facilitate drug development and increase cost-effectiveness in health care. In her PhD thesis, which she will defend on December 21st , Netherlands Cancer Institute researcher Fleur Weeber describes several research projects on personalized medicine in cancer.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2016 805
Total impact of publications in 2014 3935
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page